These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 19335722)

  • 1. Vaccine immunology.
    Bartlett BL; Pellicane AJ; Tyring SK
    Dermatol Ther; 2009; 22(2):104-9. PubMed ID: 19335722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches in vaccine development.
    Leclerc C
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):329-41. PubMed ID: 12818620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines for emerging infections.
    Marano N; Rupprecht C; Regnery R
    Rev Sci Tech; 2007 Apr; 26(1):203-15. PubMed ID: 17633303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immunity and new adjuvants.
    Mutwiri G; Gerdts V; Lopez M; Babiuk LA
    Rev Sci Tech; 2007 Apr; 26(1):147-56. PubMed ID: 17633299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Veterinary vaccines for animal and public health.
    Pastoret PP; Jones P
    Dev Biol (Basel); 2004; 119():15-29. PubMed ID: 15742615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of oral vaccines for disease control in wildlife species.
    Cross ML; Buddle BM; Aldwell FE
    Vet J; 2007 Nov; 174(3):472-80. PubMed ID: 17113798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction.
    Mills KH
    Immunol Lett; 2009 Feb; 122(2):108-11. PubMed ID: 19100777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Eradication of infectious diseases by vaccination].
    Saliou P
    Med Trop (Mars); 2007 Aug; 67(4):321-7. PubMed ID: 17926788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of vaccines.
    Bartlett BL; Tyring SK
    Dermatol Ther; 2009; 22(2):97-103. PubMed ID: 19335721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in the response to vaccination.
    Kimman TG; Vandebriel RJ; Hoebee B
    Community Genet; 2007; 10(4):201-17. PubMed ID: 17895626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The place of marker vaccines in control and eradication of animal diseases--aspects of comparative interest.
    Pastoret PP
    Dev Biol (Basel); 2005; 121():181-8. PubMed ID: 15962481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological basics of vaccination].
    Dalpke AH
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S61-4. PubMed ID: 19353473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosenescence: Implications for vaccination programmes in adults.
    Lang PO; Govind S; Michel JP; Aspinall R; Mitchell WA
    Maturitas; 2011 Apr; 68(4):322-30. PubMed ID: 21316879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive models and correlates of protection for testing biodefence vaccines.
    Williamson ED; Duchars MG; Kohberger R
    Expert Rev Vaccines; 2010 May; 9(5):527-37. PubMed ID: 20450327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccine failure].
    Schaad UB
    Schweiz Med Wochenschr; 1987 May; 117(22):845-8. PubMed ID: 3474780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines for the prevention of diseases caused by potential bioweapons.
    Hassani M; Patel MC; Pirofski LA
    Clin Immunol; 2004 Apr; 111(1):1-15. PubMed ID: 15093546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decade of vaccines: Integrating immunology and vaccinology for rational vaccine design.
    D'Argenio DA; Wilson CB
    Immunity; 2010 Oct; 33(4):437-40. PubMed ID: 21029955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential disruptive technology in vaccine development: gene-based vaccines and their application to infectious diseases.
    Kaslow DC
    Trans R Soc Trop Med Hyg; 2004 Oct; 98(10):593-601. PubMed ID: 15289096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Veterinary vaccines and their use in developing countries.
    Lubroth J; Rweyemamu MM; Viljoen G; Diallo A; Dungu B; Amanfu W
    Rev Sci Tech; 2007 Apr; 26(1):179-201. PubMed ID: 17633302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosenescence and herd immunity: with an ever-increasing aging population do we need to rethink vaccine schedules?
    Lang PO; Aspinall R
    Expert Rev Vaccines; 2012 Feb; 11(2):167-76. PubMed ID: 22309666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.